The Effectiveness of Ultra-Sound Guided Erector Spinae Block With Betamethasone for Management of Truncal Chronic Post Herpetic Neuralgia.
The Effectiveness of Ultra-Sound Guided Erector Spinae Block With Betamethasone for Management of Truncal Chronic Post Herpetic Neuralgia, a Prospective Randomized Controlled Study.
Cairo University
40 participants
May 1, 2025
INTERVENTIONAL
Conditions
Summary
To investigate the effectiveness of ultra-Sound guided Erector spinae block (ESB) with Betamethasone as an adjuvant to standard medical protocol in the management of truncal chronic post herpetic neuralgia.
Eligibility
Inclusion Criteria3
- Patients age between 18 and 75.
- Patients with American Society of Anesthesiologists (ASA) II and III status.
- Patients diagnosed with truncal chronic post herpetic neuralgia( neuropathic pain persistent for more than 3 months from the onset of rash appearance )
Exclusion Criteria7
- Patients unable to comprehend the informed consent.
- Patients on long term opioid regimens.
- Patients with impairment in hepatic (Alanine aminotransferase (ALT) \>50 U/L, and/or Aspartate aminotransferase (AST): \>45 U/L) or renal functions( creatinine level ≥1.5 mg/dL)
- Patients on anti-coagulation regimens.
- Patients with coagulation abnormalities (i.e. international normalized ratio (INR) ≥1.5 and/or platelets ≤50000)
- Local infection in the site of the block.
- Patients with body mass index (BMI) \> 35.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will receive the standard medical regimen alone.
Patients will receive erector spinae plane (ESP) block with betamethasone with standard medical regimen.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07000409